Several authors have already applied SEREX to glioma, and some antigens, including glioma-expressed antigen 2 (GLEA2)[7], PHD finger protein 3 (PHF3)[7,34], and SRY-box 6 (SOX6)[8] have been identified. This evidence concerns the gene SOX6 and central nervous system cancer.